MaganaMed — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

MaganaMed is a private, owner-managed software company offering a validated, cloud-based EDC/eCRF platform for clinical research. Its core value proposition is an intuitive, modular system that allows for rapid study configuration, emphasizing ease of use, full regulatory compliance, and transparent pricing. The company serves a diverse client base, including academic institutions, CROs, and medical device companies, for clinical trials and post-market studies. With a strong focus on customer partnership and data security, MaganaMed is positioned as a reliable, mid-market alternative to larger, more complex clinical trial software vendors.

Medical DevicesDigital Health

Technology Platform

Browser-based, modular Electronic Data Capture (EDC) and electronic Case Report Form (eCRF) software (Magana Trial Manager) for clinical trials and post-market surveillance. Features include multicenter management, query handling, ePRO surveys, biosample tracking, visit scheduling, randomization, and API access.

Opportunities

Significant opportunity in the mid-market and specialist clinical research segment (academic, small CROs, medtech) where large enterprise EDC systems are often too complex and expensive.

The growing regulatory demand for post-market surveillance (PMS/PMCF) of medical devices, especially in Europe under the MDR, creates a dedicated and expanding need for flexible, compliant data collection tools.

Risk Factors

Faces intense competition from large, established clinical trial software vendors (e.g., Veeva, Medidata) and other agile startups.

Success is dependent on the overall funding environment for clinical research, particularly in its core academic and SME market.

Requires continuous investment to maintain and update regulatory validations (GCP, FDA 21 CFR Part 11, GDPR) as standards evolve.

Competitive Landscape

Operates in the competitive Electronic Data Capture (EDC) and Clinical Trial Management System (CTMS) market, dominated by large players like Veeva and Medidata. Differentiation is achieved through a focus on intuitive user experience, rapid deployment, modular transparent pricing, and a customer-partnership model, targeting users who find enterprise solutions overly complex. Competitors include other niche EDC providers and generic data collection tools adapted for clinical use.

More companies in Digital Health & Biotech SaaS →More companies in Germany →